Phase 2
๐ Investigational Drug / Biologic
NCT05345002
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
๐ University of Pennsylvania โ Philadelphia, Pennsylvania
View Study & Screener โ